Investing Profile

Chris Nave

InvestorVC
Managing Director at Brandon Capital
brandoncapital.vc/team_member...Melbourne, Australia
Photo of Chris Nave, Managing Director at Brandon Capital Partners
Your Intro Paths to Chris Nave

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Chris is a member of
Brandon Capital Network
17 CONNECTIONS

Find Chris Nave on

cb
Current Investing Position
Brandon Capital Partners Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
21
Current Fund Size
$404.5M

Chris Nave is on these Sector & Stage Rankings

Chris Nave's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
Ena Respiratory
Series BOct 2025$22M
Series UnknownJun 2021$24M
Series ASep 2020$8M
Series UnknownMay 2017$5M
$59M
Co-investors: Christopher Smith (Brandon Capital Partners)
PolyActiva
Series CMay 2025$26M
Series BFeb 2013$10M
$36M
Denteric
GrantJul 2022
Series ASep 2019$9M
$9M
Azura Ophthalmics
Series COct 2020$20M
Series BOct 2017$16M
$36M
Co-investors: Heather Preston (Oxonian Ventures )
Pathios Therapeutics
Series ADec 2019$13M
$38M
Co-investors: Brent Ahrens (Canaan Partners)
EBR Systems
Private EquityAug 2019$30M
Private EquityNov 2017$50M
$140M
Co-investors: Jason Lettmann (Morgenthaler Ventures)
Certa Therapeutics
GrantJun 2018$19M
$19M
OccuRx
Series UnknownMay 2015$5M
$5M

Chris Nave's Experience

board of directors Fibrotech TherapeuticsPresent
manager of biotechnology Fibrotech TherapeuticsPresent
business development Fibrotech TherapeuticsPresent
director of commercialization Fibrotech TherapeuticsPresent
non-executive director Fibrotech TherapeuticsPresent
chairman and non-executive director Fibrotech TherapeuticsPresent
PhD Melbourne UniversityPresent
PhD Fibrotech TherapeuticsPresent
Manager, Biotechnology Fibrotech TherapeuticsPresent
Manager, Biotechnology Melbourne VenturesPresent
Director, Commercialisation Fibrotech TherapeuticsPresent
Director, Commercialisation Baker Heart Research InstitutePresent
Principal Executive Fibrotech TherapeuticsPresent
Principal Executive Medical Research Commercialisation Fund (MRCF)Present
Managing Director Brandon CapitalPresent
Managing Director Brandon Capital PartnersPresent

Investors who invest with Chris Nave

Sign in with Google →

Scouts & Angels Affiliated With Chris Nave

Sign in with Google →